These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26659468)

  • 1. OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
    Matthaei J; Kuron D; Faltraco F; Knoch T; Dos Santos Pereira JN; Abu Abed M; Prukop T; Brockmöller J; Tzvetkov MV
    Clin Pharmacol Ther; 2016 Jun; 99(6):633-41. PubMed ID: 26659468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
    Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
    Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
    Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
    Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment.
    Tfelt-Hansen P
    J Headache Pain; 2007 Oct; 8(5):273-6. PubMed ID: 17955173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans.
    Jensen O; Matthaei J; Blome F; Schwab M; Tzvetkov MV; Brockmöller J
    Clin Pharmacol Ther; 2020 Mar; 107(3):628-638. PubMed ID: 31593619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
    Ellawatty WEA; Masuo Y; Fujita KI; Yamazaki E; Ishida H; Arakawa H; Nakamichi N; Abdelwahed R; Sasaki Y; Kato Y
    Drug Metab Dispos; 2018 Jan; 46(1):33-40. PubMed ID: 29089306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity.
    Morse BL; Fallon JK; Kolur A; Hogan AT; Smith PC; Hillgren KM
    AAPS J; 2021 Apr; 23(3):58. PubMed ID: 33903987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1.
    Saadatmand AR; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
    Biochem Pharmacol; 2012 May; 83(10):1427-34. PubMed ID: 22342776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
    Tzvetkov MV; Vormfelde SV; Balen D; Meineke I; Schmidt T; Sehrt D; Sabolić I; Koepsell H; Brockmöller J
    Clin Pharmacol Ther; 2009 Sep; 86(3):299-306. PubMed ID: 19536068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
    Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
    Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
    Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
    Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.
    Meyer MJ; Seitz T; Brockmöller J; Tzvetkov MV
    PLoS One; 2017; 12(12):e0189521. PubMed ID: 29236753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan fast-disintegrating/rapid-release tablets: viewpoints.
    Carpay HA; Dowson AJ
    Drugs; 2006; 66(6):891-2. PubMed ID: 16706566
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron.
    Tzvetkov MV; Saadatmand AR; Bokelmann K; Meineke I; Kaiser R; Brockmöller J
    Pharmacogenomics J; 2012 Feb; 12(1):22-9. PubMed ID: 20921968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human organic cation transporter OCT1 and its role as a target for drug responses.
    Brosseau N; Ramotar D
    Drug Metab Rev; 2019 Nov; 51(4):389-407. PubMed ID: 31564168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    Bussone G; D'Amico D; McCarroll KA; Gerth W; Lines CR
    Eur Neurol; 2002; 48(3):172-7. PubMed ID: 12373035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions.
    Zamek-Gliszczynski MJ; Giacomini KM; Zhang L
    Clin Pharmacol Ther; 2018 May; 103(5):758-760. PubMed ID: 29193038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
    Vishwanathan K; Bartlett MG; Stewart JT
    Rapid Commun Mass Spectrom; 2000; 14(3):168-72. PubMed ID: 10637423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
    Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
    Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.